JP Morgan maintains Intl Flavors & Fragrances at Overweight, raises price target to $95 from $92

JP Morgan maintained its Overweight rating on Intl Flavors & Fragrances (IFF) and raised its price target to $95 from $92, suggesting a 10% upside from the Nov 5 close of $86.36. Recent analyst price targets for IFF range from $95 to $108.

Original reporting
Published Nov 5, 2026, 11:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 11:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
JP Morgan maintains Intl Flavors & Fragrances at Overweight, raises price target to $95 from $92 — source image
Decision brief

The 30-second read

$IFFBullishLow
01

Why it matters

The upgrade could prompt short‑term buying pressure, but the effect may be muted without fresh operational news.

02

Market read

Analyst rating change is a modest catalyst for IFF and may influence sector peers.

03

What to watch

No new fundamental data accompanies the target change; reliance on analyst opinion alone.

Relevance 5/10Novelty 5/10Timing: today

Background

JP Morgan maintains an Overweight rating on IFF and lifts its price target by 3.3% to $95.

Company-level read

Ticker impact

$IFFBullishMedium confidence
Context

JP Morgan raised its price target on International Flavors & Fragrances to $95 from $92.

Expected impact

likely upward pressure as investors price in the higher target

Evidence & confidence

Target increase signals improved expectations, which can attract buying interest.

Market effects

May lift sentiment for the consumer‑goods and specialty chemicals sector.

U.S. equity market could see modest gain in related stocks.

Limited to investors tracking analyst coverage of consumer‑goods companies.

Counterpoint

Target raise may already be priced in; price could stall if earnings disappoint.

Key entities

  • International Flavors & Fragrances Inc.

    U.S.-listed specialty chemicals and flavor company (ticker IFF).

  • JP Morgan

    Investment bank providing the rating and price target.

Related articles

$IFFMedAI 8/10

International Flavors & Fragrances Q3 Earnings Call Highlights

International Flavors & Fragrances (IFF) reported Q3 sales of $566M in Health & Biosciences, up 1%. Full-year sales are expected to be $7.5B-$7.6B, with adjusted EBITDA of $1.55B-$1.6B. IFF faces cost pressures, particularly in Health & Biosciences, due to higher input costs. The company plans to divest its Food Ingredients business for $4.3B by mid-2027 and has completed other divestitures. Free cash flow for the first nine months of 2026 was $371M, up $245M year-over-year.

$IFFMed

International Flavors & Fragrances Inc (IFF) (Q3 2026) Earnings Call

International Flavors & Fragrances Inc (IFF) reported challenges in its Health business due to reduced consumer spending in the US and Europe. The company expects higher costs in Q4 2026, with net price to input costs remaining unfavorable. Profitability margins are expected to moderate due to seasonality and higher costs. IFF faces execution risks related to the separation of its Food Ingredients business.

$IFFHigh

BofA downgrades International Flavors & Fragrances stock rating on valuation concerns

BofA downgraded International Flavors & Fragrances (IFF) to Underperform, lowering its price target to $91. IFF reported Q3 adjusted EBITDA of $403M, beating estimates. Despite strong results, BofA cited valuation concerns, softness in non-Taste businesses, and rising costs. IFF's stock declined post-earnings due to near-term margin concerns, though management raised full-year guidance.

$IFFHighAI 8/10

Intl Flavors (IFF) Q3 2026 Earnings Call Transcript

Intl Flavors (IFF) reported Q3 2026 earnings with 5% revenue growth and 6% EBITDA increase, driven by strong performances in taste and scent segments. The company raised its full-year guidance, completed a $500M share repurchase, and announced strategic divestitures, including the sale of its food ingredients business for $4.3B. Free cash flow rose to $371M, up $245M YoY. IFF expects near-term softness in Health & Biosciences but remains confident in its growth strategy.

$IFFMedAI 9/10

IFF Q3 2026 slides: solid growth tempered by margin headwinds

International Flavors & Fragrances (IFF) reported Q3 2026 earnings with revenue of $1.94B and adjusted EPS of $0.83, beating expectations. Shares fell 3.83% due to margin concerns and guidance for softer Q4 profitability. IFF highlighted growth in Taste, Scent, and Health & Biosciences segments, along with a $4.3B sale of its Food Ingredients business and a $2.5B capital return program. Free cash flow improved to $371M, up $245M YoY.